Deoxyuridine

DBCAT000608Pharmacologic class

2'-Deoxyuridine. An antimetabolite that is converted to deoxyuridine triphosphate during DNA synthesis. Laboratory suppression of deoxyuridine is used to diagnose megaloblastic anemias due to vitamin B12 and folate deficiencies. A DrugBank category of 6 drugs. 3 of them are approved.

Also known as: (beta 1-(2-Deoxyribopyranosyl))thymidine
Drugs: Brivudine
Broxuridine
Doxifluridine
Floxuridine
Idoxuridine
Thymectacin

What you can answer from here — as of August 24, 2016

6DrugsEach linked to its full drug card

Listed above

8Drug targetsEvery drug–target pair in the class, with bond type

29Marketed productsAcross the regions we cover, with dosage forms and routes

4Routes of administrationHow the drugs in this class are given

Which targets do Deoxyuridine share, and which companies have late-stage candidates in this class?

Answer this in Biopharma OS Sign in to your account

Create a free account or log in to explore the full data card.

Create Account